Company Filing History:
Years Active: 2005-2006
Title: An Insight into the Innovations of Inventor Ulrike Bauer
Introduction
Ulrike Bauer is a prominent inventor based in Sandhausen, Germany, known for her significant contributions to the field of nuclear receptor binding compounds. With a total of three patents to her name, she has made remarkable strides in the development of innovative compounds that have the potential to treat various diseases and conditions.
Latest Patents
Among her latest patents, the invention titled "FXR NR1H4 Nuclear Receptor Binding Compounds" showcases compounds designed to bind to the NRH receptor. This invention describes how these compounds act as agonists, antagonists, or mixed agonists/antagonists of the NRH receptor. Additionally, it outlines methods for treating diseases and conditions through the binding of the nuclear receptor by these compounds and the production of medicaments utilizing them.
Another significant patent she holds is focused on "NR1H4 Nuclear Receptor Binding Compounds." This invention also features compounds that bind to the NR1H4 nuclear receptor, with applications as agonists and antagonists. This research opens new avenues for the treatment of various medical conditions by leveraging the unique properties of these compounds.
Career Highlights
Ulrike Bauer has had a successful career, working with respected organizations in the pharmaceutical field. She has gained valuable experience at Phenex Pharmaceuticals AG, where her contributions have been essential to the company's advancements in medicinal chemistry and drug development. Her innovative work and research have played a role in shaping the future of therapeutic options in this area.
Collaborations
Throughout her career, Ulrike has collaborated with notable colleagues, including Zach Cheruvallath and Ulrich Deuschle. These partnerships have likely contributed to her endeavors and aided in advancing the scope of her research and inventions.
Conclusion
Ulrike Bauer's work stands as a testament to her dedication and ingenuity in the field of nuclear receptor research. With several patents that offer promising solutions for medical treatments, she continues to be an influential figure in advancing therapeutic methodologies. Her innovative spirit and collaborative approach with industry professionals contribute to the ongoing evolution of medical science and patient care.